How many investments has Kleinmuntz Associates made?

Kleinmuntz Associates has 9 tracked investments.

What stage does Kleinmuntz Associates invest at?

Kleinmuntz Associates invests at the Seed, Series A stages.

What sectors does Kleinmuntz Associates focus on?

Kleinmuntz Associates focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices.

Where is Kleinmuntz Associates located?

Kleinmuntz Associates is headquartered in Chicago, US.

Kleinmuntz Associates

Venture capital

Chicago · Seed–Series A · 2 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Kleinmuntz Associates

Your email: who you already know at Kleinmuntz Associates, and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Kleinmuntz Associates team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

✨ Fox Verdict

Investment thesis

Founded in 2013, Kleinmuntz Associates focuses on early-stage start-up investments at the intersection of analytics, biotechnology, and healthcare. The firm combines capital investment with hands-on business advisory services, drawing on its principals' decades of operating and academic experience in healthcare analytics and decision science. Investments span molecular diagnostics, computational oncology, therapeutics, and technology-enabled consumer and SaaS platforms.

Invests inAI & Machine Learning Biotech Digital Health Healthtech Medical Devices Chicago United States

Source: firm website, verified Oct 2, 2026.

Leave your own feedback

Stage

Seed–Series A

Chicago, US

Instruments

Equity

Founded

2013

Tracked investments

Unicorns

Team · 2 people

from the firm's website

Catherine Kleinmuntz· Principal

Principal at Kleinmuntz Associates and co-Executive Director of the Kleinmuntz Family Foundation. She co-founded Strata Decision Technology in 1996, serving as President and CEO until its 2011 sale, and holds degrees from the University of Chicago including an MBA from Booth.

Don Kleinmuntz· Principal

Principal at Kleinmuntz Associates and co-Executive Director of the Kleinmuntz Family Foundation. An expert in decision analysis and business analytics, he co-founded Strata Decision Technology, held academic posts at several universities, and served as INFORMS President in 2009.

What they invest in

from 4 of 9 portfolio companies

Biotech ×4Medical Devices ×4Healthtech ×3AI & Machine Learning ×2Deep Tech ×1Digital Health ×1

HQs:United States×4

Investments · 9 tracked

founders shown can be your intro path

Cameocameo.com

Marketplace enabling users to request personalized video messages or live chats with celebrities and influencers.

Steven Galanis(Co-founder)inMartin Blencowe(Founder)in Devon Spinnler Townsend(Co-founder)in

Co-investorsChaifetz Group Chicago Ventures Cleo Capital Connect Ventures Digi Ventures Duke Capital Partners +23 more

CampfireSocialcampfiresocialagency.com

eterna teareternatear.com in

Eternatear develops diagnostic and therapeutic products for dry eye disease, particularly targeting Meibomian Gland Dysfunction.

BiotechHealthtechMedical DevicesRaleigh, US

Tim Willis(CEO, Chairman of the Board)Ralph Stone(Chief Technology Officer)Joe Huber(Chief Operating Officer)Diethart Reichardt(Chief Marketing Officer & Board Director)

Co-investorsCharlotte Angel Fund Duke Capital Partners

Finch Therapeuticsfinchtherapeutics.com in 𝕏

Finch Therapeutics is a life sciences company focused on the development and protection of drug-related intellectual property and therapeutics within the biotechnology and pharmaceutical industry.

BiotechHealthtechMedical DevicesSomerville, US

Mark Smith(Executive Officer, Director)in Matt Blischak(Chief Executive Officer)inR. J. Price(Director)Jeffery A. Smisek(Director)Andrew Mulderry(Director)James Burgess(Director)

Co-investorsAvenir Growth Capital B3 Holding Octave Ventures Llc OCV Partners OMX Ventures Shumway Capital +2 more

OMX Venturesomx.vc

Origin Venturesoriginventures.com

Simbiosyssimbiosys.com in 𝕏

SimBioSys builds AI-powered 3D visualization and diagnostic technology that models tumors as "digital twins" to support individualized cancer treatment planning.

AI & Machine LearningBiotechDigital HealthMedical DevicesChicago, US

Joe Peterson(Co-founder)John Cole(Co-founder)Tushar Pandey(Co-founder)in Stacey Stevens(Executive Officer, Director)in

Board Vikram Chaudhery(Director)inLucy Coassin(Director)

Co-investorsAV8 Ventures Genoa Ventures GENERAL INCEPTION Northpond Ventures

StatusNOWstatusnowsolutions.com

VedaBiovedabio.com inSeed

VedaBio develops a molecular detection platform using CRISPR technology that enables rapid, accurate detection of multiple biological targets without the need for amplification.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSan Diego, US

Anurup Ganguli(Founder)inFred(President and CEO)Frédéric Sweeney(President and Chief Executive Officer)inMaurice Exner(Chief Operating Officer)in

Co-investorsIllinois Ventures OMX Ventures Y Combinator Evergreen Venture Partners Fox Ventures

Portfolio news

latest coverage across their companies

VedaBio Announces Strategic Agreement with Siemens Healthineers and Series A Extension, Totaling Up to $25 Million - BioSpace

VedaBio · biospace.com · Sep 23, 2025

Frequently asked questions

How many investments has Kleinmuntz Associates made?: Kleinmuntz Associates has 9 tracked investments.
What stage does Kleinmuntz Associates invest at?: Kleinmuntz Associates invests at the Seed, Series A stages.
What sectors does Kleinmuntz Associates focus on?: Kleinmuntz Associates focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices.
Where is Kleinmuntz Associates located?: Kleinmuntz Associates is headquartered in Chicago, US.

Featured in lists